Lung Cancer News and Research

Latest Lung Cancer News and Research

Bevacizumab/paclitaxel/carboplatin regimen attains gold-standard status for treatment of non-small-cell lung cancer

Bevacizumab/paclitaxel/carboplatin regimen attains gold-standard status for treatment of non-small-cell lung cancer

GPC5 gene associated with lung cancer in 'never-smokers'

GPC5 gene associated with lung cancer in 'never-smokers'

Clinical data of dendritic cell based vaccine to be presented at Cancer Stem Cells Conference

Clinical data of dendritic cell based vaccine to be presented at Cancer Stem Cells Conference

InvestorSoup.com announces investment report featuring Oncothyreon

InvestorSoup.com announces investment report featuring Oncothyreon

Merck Serono, EMD Serono suspend global clinical development program for Stimuvax temporarily

Merck Serono, EMD Serono suspend global clinical development program for Stimuvax temporarily

CT colonography screening identifies unsuspected cancer outside of colon

CT colonography screening identifies unsuspected cancer outside of colon

Simcere Pharmaceutical completes Phase IV clinical study of Endostar

Simcere Pharmaceutical completes Phase IV clinical study of Endostar

Formatech selects Tracon Pharmaceuticals’ TRC102 inhibitor as next Fillanthropy Program candidate

Formatech selects Tracon Pharmaceuticals’ TRC102 inhibitor as next Fillanthropy Program candidate

Mayo Clinic co-led research finds first gene linked to lung cancer in "never smokers"

Mayo Clinic co-led research finds first gene linked to lung cancer in "never smokers"

Safe to smoke?

Safe to smoke?

European CHMP issues positive opinion for Roche's Tarceva as maintenance therapy for NSCLC

European CHMP issues positive opinion for Roche's Tarceva as maintenance therapy for NSCLC

CHMP issues positive opinion recommending approval of Tarceva as monotherapy for NSCLC

CHMP issues positive opinion recommending approval of Tarceva as monotherapy for NSCLC

Novelos Therapeutics Phase 3 trial of NOV-002 in advanced NSCLC fails to meet primary and secondary endpoints

Novelos Therapeutics Phase 3 trial of NOV-002 in advanced NSCLC fails to meet primary and secondary endpoints

InvestorSoup.com: CYCC's total revenues for third-quarter of 2009 decrease by 14%

InvestorSoup.com: CYCC's total revenues for third-quarter of 2009 decrease by 14%

SBRT can improve survival rates for patients with inoperable non-small cell lung cancer

SBRT can improve survival rates for patients with inoperable non-small cell lung cancer

Cryotherapy may become the future treatment for cancer

Cryotherapy may become the future treatment for cancer

SBRT doubles rate of primary tumor control compared to conventional radiotherapy

SBRT doubles rate of primary tumor control compared to conventional radiotherapy

Biomoda enters into agreements with syndicate of institutional investors for up to $2.0M

Biomoda enters into agreements with syndicate of institutional investors for up to $2.0M

ImmunoCellular Therapeutics receives Notice of Allowance covering antibodies targeting pancreatic cancer

ImmunoCellular Therapeutics receives Notice of Allowance covering antibodies targeting pancreatic cancer

Abraxis BioScience's Phase 3 trial comparing ABRAXANE with Taxol injection meets primary endpoint

Abraxis BioScience's Phase 3 trial comparing ABRAXANE with Taxol injection meets primary endpoint

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.